Tandem Diabetes Care (TNDM) Change in Account Payables (2013 - 2026)
Tandem Diabetes Care (TNDM) posted Change in Account Payables of $13.8 million for Q1 2026, up 136.4% on a QoQ basis from $5.8 million in Q4 2025, and up 107.23% year-over-year from $6.6 million in Q1 2025.
Tandem Diabetes Care (TNDM) Change in Account Payables (2013 - 2026) Analysis & Trends
Tandem Diabetes Care's Change in Account Payables history runs 12 years deep, the most recent figure standing at $13.8 million for Q1 2026.
- Quarterly Change in Account Payables rose 107.23% year-over-year to $13.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.3 million (up 22.72% YoY) and the FY2025 annual result came in at $2.2 million, up 193.1% from the prior year.
- Change in Account Payables was $13.8 million for Q1 2026 at Tandem Diabetes Care, up from $5.8 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $13.8 million in Q1 2026 and bottomed at -$9.3 million in Q3 2025.
- A 3-year average of $1.5 million and a median of -$898000.0 in 2025 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 504.03% in 2025, while the deepest fall reached 682.06% in 2025.
- Tandem Diabetes Care's Change in Account Payables stood at -$1.4 million in 2024, then soared by 504.03% to $5.8 million in 2025, then surged by 136.4% to $13.8 million in 2026.
- Business Quant data shows TNDM's Change in Account Payables at $13.8 million in Q1 2026, $5.8 million in Q4 2025, and -$9.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 221.00 Mn |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 585.31 Mn | 136.79 Mn | 13.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.75 Mn |
| Mar 31, 2026 | 13.75 Mn |
| Dec 31, 2025 | 5.82 Mn |
| Dec 31, 2025 | 5.82 Mn |
| Sep 30, 2025 | -9.33 Mn |
| Sep 30, 2025 | -9.33 Mn |
| Jun 30, 2025 | -898,000.00 |
| Jun 30, 2025 | -898,000.00 |
| Mar 31, 2025 | 6.64 Mn |
| Mar 31, 2025 | 6.64 Mn |
| Dec 31, 2024 | -1.44 Mn |
| Dec 31, 2024 | -1.44 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Jun 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | 3.61 Mn |
| Mar 31, 2024 | -3.37 Mn |
| Mar 31, 2024 | -3.37 Mn |
| Mar 31, 2021 | 10.54 Mn |
| Mar 31, 2021 | 10.54 Mn |